Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.
Fleseriu M, Pivonello R, Elenkova A, Salvatori R, Auchus RJ, Feelders RA, Geer EB, Greenman Y, Witek P, Cohen F, Biller BMK. Fleseriu M, et al. Among authors: cohen f. Lancet Diabetes Endocrinol. 2019 Nov;7(11):855-865. doi: 10.1016/S2213-8587(19)30313-4. Epub 2019 Sep 18. Lancet Diabetes Endocrinol. 2019. PMID: 31542384 Clinical Trial.
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.
Pivonello R, Elenkova A, Fleseriu M, Feelders RA, Witek P, Greenman Y, Geer EB, Perotti P, Saiegh L, Cohen F, Arnaldi G. Pivonello R, et al. Among authors: cohen f. Front Endocrinol (Lausanne). 2021 Apr 7;12:595894. doi: 10.3389/fendo.2021.595894. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33897615 Free PMC article. Clinical Trial.
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.
Fleseriu M, Auchus RJ, Greenman Y, Zacharieva S, Geer EB, Salvatori R, Pivonello R, Feldt-Rasmussen U, Kennedy L, Buchfelder M, Biller BM, Cohen F, Heaney AP. Fleseriu M, et al. Among authors: cohen f. Eur J Endocrinol. 2022 Nov 24;187(6):859-871. doi: 10.1530/EJE-22-0506. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36251618 Free PMC article. Clinical Trial.
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
Geer EB, Salvatori R, Elenkova A, Fleseriu M, Pivonello R, Witek P, Feelders RA, Bex M, Borresen SW, Puglisi S, Biller BMK, Cohen F, Pecori Giraldi F. Geer EB, et al. Among authors: cohen f. Pituitary. 2021 Feb;24(1):116. doi: 10.1007/s11102-020-01116-1. Pituitary. 2021. PMID: 33313999 Free PMC article. No abstract available.
Levoketoconazole in the treatment of patients with endogenous Cushing's syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS).
Pivonello R, Zacharieva S, Elenkova A, Tóth M, Shimon I, Stigliano A, Badiu C, Brue T, Georgescu CE, Tsagarakis S, Cohen F, Fleseriu M. Pivonello R, et al. Among authors: cohen f. Pituitary. 2022 Dec;25(6):911-926. doi: 10.1007/s11102-022-01263-7. Epub 2022 Sep 9. Pituitary. 2022. PMID: 36085339 Free PMC article. Clinical Trial.
Sensitivity and specificity of the macimorelin test for diagnosis of AGHD.
Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Swerdloff R, Wang C, Fleming RR, Cohen F, Ammer N, Mueller G, Kelepouris N, Strobl F, Ostrow V, Yuen KCJ. Garcia JM, et al. Among authors: cohen f. Endocr Connect. 2021 Jan;10(1):76-83. doi: 10.1530/EC-20-0491. Endocr Connect. 2021. PMID: 33320108 Free PMC article.
765 results